Dementia News and Research

Latest Dementia News and Research

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease.

24 Mar 2021

Changes in OASI gene expression increases risk of Alzheimer's and severe COVID-19 infection

Previous research identified the interferon-responsive OAS1 gene as a risk gene for Alzheimer's disease. OAS1 is an enzyme that binds to double-stranded RNA and induces the conformation to create oligoadenylates. They also activate RNase L to break down RNA.

23 Mar 2021

Exercise increases blood flow to the brain, study shows

It's not just your legs and heart that get a workout when you walk briskly; exercise affects your brain as well. A new study by researchers at UT Southwestern shows that when older adults with mild memory loss followed an exercise program for a year, the blood flow to their brains increased.

23 Mar 2021

Socioeconomic deprivation linked to large proportion of dementia deaths in England, Wales

A large proportion of dementia deaths in England and Wales may be due to socioeconomic deprivation, according to new research led by Queen Mary University of London.

23 Mar 2021

Nutritional supplement may reduce risk of fatal strokes in patients with rare genetic disorder

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered that a widely used nutritional supplement may significantly reduce the risk of fatal strokes caused by a rare genetic disorder.

23 Mar 2021

Researchers test novel gene regulation approach to treat brain diseases

Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer's in laboratory studies.

22 Mar 2021

Consumption of processed meat associated with increased risk of dementia

Scientists from the University of Leeds's Nutritional Epidemiology Group used data from 500,000 people, discovering that consuming a 25g serving of processed meat a day, the equivalent to one rasher of bacon, is associated with a 44% increased risk of developing the disease.

21 Mar 2021

Researchers unveil a neuroprotective pathway that suppresses ALS

In general, the RAN proteins are more abundant in the cell nucleus, but in patients with Lou Gehrig's disease, they begin to leak out into the cytoplasm, thereby resulting in abnormal concentration differences.

19 Mar 2021

Maintaining a stable body weight does not reduce risk of death in colorectal cancer survivors

Colorectal cancer survivors who maintained a stable body weight but lost muscle and developed fatty deposits in their muscles faced a 40 percent higher risk of premature death than patients who avoided both health issues.

19 Mar 2021

New Alzheimer's model may help test novel treatments

Our knowledge of Alzheimer's disease has grown rapidly in the past few decades but it has proven difficult to translate fundamental discoveries about the disease into new treatments.

18 Mar 2021

Sound sleep plays a crucial role in healing traumatic brain injuries

Sound sleep plays a critical role in healing traumatic brain injury, a new study of military veterans suggests.

13 Mar 2021

Dementia risk escalates with the number and severity of strokes

Having an ischemic stroke increases dementia risk, and that risk escalates with the number and severity of strokes, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.

11 Mar 2021

A retinal photo may provide early warning signs of stroke and dementia

Pictures of the retina may someday provide early warning signs that a person is at an increased risk of stroke and dementia, making it possible to take preventive measures, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.

11 Mar 2021

Black Medicare patients with ischemic stroke die at a higher rate than white patients

A long-term look at Medicare patients shows that Black patients who have an ischemic stroke (blocked blood flow to the brain) die at a higher rate than white patients, even after accounting for preexisting health conditions, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.

11 Mar 2021

New high-performance, safe MRI contrast agent for 3D vascular mapping

Heart attack and stroke are the first and second leading causes of death in developed countries, respectively. As the disease often results in sudden death with few special prognostic symptoms, early diagnosis is very important.

10 Mar 2021

First complete atlas of how mutations affect the formation of amyloid plaques in Alzheimer’s disease

A study published in the journal eLife made all the possible mutations in the amyloid beta peptide and tested how they influence its aggregation into plaques, a pathological hallmark of Alzheimer's disease.

9 Mar 2021

New tool helps choose the best intervention for each dementia patient

Every three seconds, a new case of dementia is diagnosed somewhere in the world. The term encompasses a group of neurodegenerative diseases that have no cure and which affect memory, cognitive abilities and behavior, and includes Alzheimer's disease.

9 Mar 2021

CBD ameliorates cognitive function in experimental model of familial Alzheimer's

A two-week course of high doses of CBD helps restore the function of two proteins key to reducing the accumulation of beta-amyloid plaque, a hallmark of Alzheimer's disease, and improves cognition in an experimental model of early onset familial Alzheimer's, investigators report.

9 Mar 2021

SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research

New research led by researchers at the University of California Los Angeles and the University of Texas Southwestern Medical Center in the US suggests that functional amyloid fibrils could play an integral role in developing COVID-19 treatments.

9 Mar 2021

Inhibition of complement disrupts neurodegeneration, improves cognitive function in TBI patients

Traumatic brain injury (TBI) is a major cause of disability and a risk factor for early-onset dementia. The injury is characterized by a physical insult followed acutely by complement driven neuroinflammation.

9 Mar 2021

Dementia News and Research

Latest Dementia News and Research

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Changes in OASI gene expression increases risk of Alzheimer's and severe COVID-19 infection

Exercise increases blood flow to the brain, study shows

Socioeconomic deprivation linked to large proportion of dementia deaths in England, Wales

Nutritional supplement may reduce risk of fatal strokes in patients with rare genetic disorder

Researchers test novel gene regulation approach to treat brain diseases

Consumption of processed meat associated with increased risk of dementia

Researchers unveil a neuroprotective pathway that suppresses ALS

Maintaining a stable body weight does not reduce risk of death in colorectal cancer survivors

New Alzheimer's model may help test novel treatments

Sound sleep plays a crucial role in healing traumatic brain injuries

Dementia risk escalates with the number and severity of strokes

A retinal photo may provide early warning signs of stroke and dementia

Black Medicare patients with ischemic stroke die at a higher rate than white patients

New high-performance, safe MRI contrast agent for 3D vascular mapping

First complete atlas of how mutations affect the formation of amyloid plaques in Alzheimer’s disease

New tool helps choose the best intervention for each dementia patient

CBD ameliorates cognitive function in experimental model of familial Alzheimer's

SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research

Inhibition of complement disrupts neurodegeneration, improves cognitive function in TBI patients

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in